Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel Á. Sanz(Universitat de València), Francesco Lo‐Coco(University of Rome Tor Vergata), Pau Montesinos(Hospital Universitari i Politècnic La Fe), Harry Iland(Royal Prince Alfred Hospital), Giuseppe Avvisati(Università Campus Bio-Medico), Lionel Adès(Délégation Paris 7), Eva Lengfelder, Alan K. Burnett(Cardiff University), Pierre Fenaux(Hôpital Avicenne), Nigel H. Russell(Nottingham University Hospitals NHS Trust), Vikram Mathews(Christian Medical College, Vellore), Eduardo Magalhães Rego(Universidade de São Paulo), Bob Löwenberg(Erasmus MC), Elihu H. Estey(University of Washington), Uwe Platzbecker(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Hartmut Döhner(Universität Ulm), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Sai-Juan Chen(Shanghai Jiao Tong University), Farhad Ravandi(The University of Texas MD Anderson Cancer Center), Tomoki Naoe(National Hospital Organization), Martin S. Tallman(Midwestern University)
Cited by 655
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k